Nomination committee

The nomination committee represents the company’s shareholders. The nomination committee will prepare proposals for the general meeting’s resolutions regarding the election of the board and board fee’s, election of the external auditor and auditor’s fee, and in so far as it seems requisite, changes to the procedures in force for the nomination committee.

The nomination committee consists of the three largest shareholders of the company in terms of votes, according to Euroclear Sweden AB’s share register on 30 September. Each such shareholder shall be offered the opportunity to appoint a representative who shall, together with the Chairman of the Board, form the nomination committee. If any of these shareholders renounce from its right to appoint a representative, the right to appoint such representative shall pass to the largest shareholder in turn in terms of votes which is not already entitled to be represented on the nomination committee. The Chairman of the nomination committee shall be the member who represents the largest shareholder in terms of votes.

Notice of the general meetings will be published in Post- och Inrikes Tidningar (the Swedish Official Gazette) and will be kept available on the company’s website. At the time of the notice, an announcement with information that the notice has been issued shall be published in Svenska Dagbladet.

Shareholders who wish to submit proposals to the nomination committee for the annual general meeting can do so by e-mail to: generalmeeting@xspray.com. Proposals should be submitted to the nomination committee no later than seven weeks prior to the Annual General Meeting.

The nomination committee for the annual general meeting, May 2020;

  • Gillis Cullin, appionted by Östersjöstiftelsen, chairman of the nomination committee
  • Anders Bladh, appointed by Ribbskottet AB
  • Jan Dworsky, appointed by Swedbank Robur Fonder
  • Michael Wolff Jensen, chairman of the board Xspray Pharma AB